Zobrazeno 1 - 10
of 197
pro vyhledávání: '"Giuliana, Cangemi"'
Autor:
Alessia Cafaro, Sebastiano Barco, Federica Pigliasco, Chiara Russo, Marcello Mariani, Alessio Mesini, Carolina Saffioti, Elio Castagnola, Giuliana Cangemi
Publikováno v:
Journal of Mass Spectrometry and Advances in the Clinical Lab, Vol 31, Iss , Pp 33-39 (2024)
Therapeutic drug monitoring (TDM) is a critical clinical tool used to optimize the safety and effectiveness of drugs by measuring their concentration in biological fluids. These fluids are primarily plasma or blood. TDM, together with real-time dosag
Externí odkaz:
https://doaj.org/article/0c9d1082b1aa4402a050df52d31bfc37
Autor:
Ursula Pia Ferrara, Cristina Tortora, Carmen Rosano, Antonia Assunto, Alessandro Rossi, Stefano Pagano, Mariateresa Falco, Chiara Simeoli, Rosario Ferrigno, Alessandra D’Amico, Dario Di Salvio, Giuliana Cangemi, Rosario Pivonello, Pietro Strisciuglio, Daniela Melis
Publikováno v:
Scientific Reports, Vol 12, Iss 1, Pp 1-9 (2022)
Abstract Bone metabolism has been rarely investigated in children affected by Neurofibromatosis type 1 (NF1). Aim of the present study was to assess bone mineral metabolism in children and adults NF1 patients, to determine the relevant factors potent
Externí odkaz:
https://doaj.org/article/76fc759798784ef096125f852a0de767
Autor:
Federica Pigliasco, Sara Malaca, Alfredo Fabrizio Lo Faro, Anastasio Tini, Giuliana Cangemi, Alessia Cafaro, Sebastiano Barco, Antonella Riva, Angelica Pisati, Elisabetta Amadori, Pasquale Striano, Adriano Tagliabracci, Marilyn Ann Huestis, Francesco Paolo Busardò
Publikováno v:
Frontiers in Pharmacology, Vol 13 (2022)
Cannabidiol (CBD) exhibits anti-inflammatory, anxiolytic, antiseizure, and neuroprotective proprieties without addictive or psychotropic side effects, as opposed to Δ9-tetrahydrocannabinol (THC). While recreational cannabis contains higher THC and l
Externí odkaz:
https://doaj.org/article/a1f45abb611b4f5ea6fc5fd22319d749
Autor:
Alessia Cafaro, Matteo Conti, Federica Pigliasco, Sebastiano Barco, Roberto Bandettini, Giuliana Cangemi
Publikováno v:
Biomedicines, Vol 11, Iss 7, p 1962 (2023)
Therapeutic drug monitoring (TDM) is a specialized area of laboratory medicine which involves the measurement of drug concentrations in biological fluids with the aim of optimizing efficacy and reducing side effects, possibly modifying the drug dose
Externí odkaz:
https://doaj.org/article/1278394bc59d4e41abcd20be5d730876
Autor:
Sara Signa, Arinna Bertoni, Federica Penco, Roberta Caorsi, Alessia Cafaro, Giuliana Cangemi, Stefano Volpi, Marco Gattorno, Francesca Schena
Publikováno v:
Frontiers in Immunology, Vol 13 (2022)
Deficiency of Adenosine deaminase 2 (DADA2) is a monogenic autoinflammatory disorder presenting with a broad spectrum of clinical manifestations, including immunodeficiency, vasculopathy and hematologic disease. Biallelic mutations in ADA2 gene have
Externí odkaz:
https://doaj.org/article/0f7f5d5d4eb849d2b3936c652ffc5e17
Autor:
Sebastiano Barco, Chiara Lavarello, Davide Cangelosi, Martina Morini, Alessandra Eva, Luca Oneto, Paolo Uva, Gino Tripodi, Alberto Garaventa, Massimo Conte, Andrea Petretto, Giuliana Cangemi
Publikováno v:
Frontiers in Oncology, Vol 12 (2022)
Neuroblastoma (NB) is the most common extracranial malignant tumor in children. Although the survival rate of NB has improved over the years, the outcome of NB still remains poor for over 30% of cases. A more accurate risk stratification remains a ke
Externí odkaz:
https://doaj.org/article/7a8128a33d5945b2aca2068cbc2d064d
Autor:
Alessia Cafaro, Federica Pigliasco, Giammarco Baiardi, Sebastiano Barco, Manuela Stella, Roberto Bandettini, Francesca Mattioli, Maura Faraci, Giuliana Cangemi
Publikováno v:
Biomedicines, Vol 11, Iss 2, p 530 (2023)
Personalization of busulfan (Bu) exposure via therapeutic drug monitoring (TDM) is recommended for patients treated with high-dose conditioning regimens. Several laboratories’ developed methods are available in the literature with a lack of standar
Externí odkaz:
https://doaj.org/article/88a38e9e0724409e9fdd33dfa2cceb45
Autor:
Federica Pigliasco, Alessia Cafaro, Manuela Stella, Giammarco Baiardi, Sebastiano Barco, Nicoletta Pedemonte, Claudia D’Orsi, Federico Cresta, Rosaria Casciaro, Carlo Castellani, Maria Grazia Calevo, Francesca Mattioli, Giuliana Cangemi
Publikováno v:
Biomedicines, Vol 11, Iss 2, p 628 (2023)
The new breakthrough cystic fibrosis (CF) drug combination of ivacaftor (IVA), tezacaftor (TEZ), and elexacaftor (ELX), namely “caftor” drugs, directly modulates the activity and trafficking of the defective CF transmembrane conductance regulator
Externí odkaz:
https://doaj.org/article/e852ddd243cc4301b126084ef5c425cf
Autor:
Alexia Tsakaneli, Victor Corasolla Carregari, Martina Morini, Alessandra Eva, Giuliana Cangemi, Olesya Chayka, Evgeny Makarov, Sandra Bibbò, Emily Capone, Gianluca Sala, Vincenzo De Laurenzi, Evon Poon, Louis Chesler, Luisa Pieroni, Martin R. Larsen, Giuseppe Palmisano, Arturo Sala
Publikováno v:
Open Biology, Vol 11, Iss 12 (2021)
Amplification of the proto-oncogene MYCN is a key molecular aberration in high-risk neuroblastoma and predictive of poor outcome in this childhood malignancy. We investigated the role of MYCN in regulating the protein cargo of extracellular vesicles
Externí odkaz:
https://doaj.org/article/12d0e9b553254367b95d2b65de857eae
Autor:
Sara Dubois, Francesca Marchese, Federica Pigliasco, Sebastiano Barco, Gino Tripodi, Tommaso Lomonaco, Simona Lattanzi, Emilio Russo, Giuliana Cangemi, Pasquale Striano
Publikováno v:
Frontiers in Pharmacology, Vol 11 (2020)
Purpose: Interest in cannabis-based therapies has recently increased, due to the availability of cannabidiol (CBD) for the treatment of epilepsy without psychoactive effects. Therapeutic drug monitoring can prevent drug interactions and minimize drug
Externí odkaz:
https://doaj.org/article/90a0ae2733d04625b9d87b7a56e5f489